Loading clinical trials...
Loading clinical trials...
A Randomized Study of the Efficacy and Safety of OncoGel™ Treatment as an Adjunctive Therapy to Systemic Chemotherapy and Concurrent External Beam Radiation Prior to Surgery in Subjects With Localized or Loco-regional Esophageal Cancer
Conditions
Interventions
OncoGel (Paclitaxel gel)
cisplatin
+3 more
Locations
20
United States
University of California San Diego
San Diego, California, United States
Rush University Medical Center
Chicago, Illinois, United States
University of Chicago Medical Center
Chicago, Illinois, United States
Indiana University Medical Center
Indianapolis, Indiana, United States
University of Kansas Medical Center
Kansas City, Kansas, United States
Thomas Jefferson University
Philadelphia, Pennsylvania, United States
Start Date
January 1, 2008
Primary Completion Date
November 1, 2010
Completion Date
November 1, 2010
Last Updated
June 22, 2022
NCT04929028
NCT07042295
NCT06980038
NCT05039801
NCT06806852
NCT04674267
Lead Sponsor
Boston Scientific Corporation
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions